5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens

被引:42
作者
Rabin, RA [1 ]
Regina, M [1 ]
Doat, M [1 ]
Winter, JC [1 ]
机构
[1] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA
关键词
5-HT2A receptor; drug discrimination; hallucinogens; phosphoinositide hydrolysis; arachidonic acid release;
D O I
10.1016/S0091-3057(01)00720-1
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The role of 5-HT2A-mediated stimulation of phosphoinositide hydrolysis in the discriminative effects of hallucinogens was investigated in PC12 cells stably expressing the rat 5-HT2A receptor (PC12-5-HT2A cells). The hallucinogenic compounds, D-lysergic acid diethylamide (LSD), (-)2,5-dimethoxy-4-methylamphetamine (DOM), psilocybin, N,N-dimethyltryptamine (DMT), 5-methoxy-N,N-dimethyltryptamine (MDMT) and N,N-diethyltryptamine (DET), all caused a concentration-dependent increase in the generation of [H-3]inisotol phosphates. The nonhallucinogenic compounds, 6-fluoro-N,N-diethyltryptamine (6-F-DET), lisuride and quipazine, also displayed significant efficacy in stimulating phosphoinositide hydrolysis, while 2-bromo-lysergic acid diethylamide (BOL), which is not a hallucinogen, did not alter inositol phosphate generation. The beta-carbolines, harmaline and harmane, also did not alter phosphoinositide hydrolysis. Comparison of these results with previous drug discrimination studies indicated the apparent lack of correlation between the degree of substitution on LSD- and DOM-trained animals and efficacy in stimulating phosphoinositide hydrolysis. The present study indicates that 5-HT2A-mediated stimulation of phosphoinositide hydrolysis does not appear to be the sole critical signaling mechanism involved in the discrimination effects of hallucinogens. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 52 条
  • [41] HALLUCINOGENIC DRUG-INTERACTIONS AT HUMAN-BRAIN 5-HT2 RECEPTORS - IMPLICATIONS FOR TREATING LSD-INDUCED HALLUCINOGENESIS
    SADZOT, B
    BARABAN, JM
    GLENNON, RA
    LYON, RA
    LEONHARDT, S
    JAN, CR
    TITELER, M
    [J]. PSYCHOPHARMACOLOGY, 1989, 98 (04) : 495 - 499
  • [42] SANDERSBUSH E, 1988, J PHARMACOL EXP THER, V246, P924
  • [43] BLOCKADE OF THE DISCRIMINATIVE STIMULUS EFFECTS OF DOI BY MDL-100,907 AND THE ATYPICAL ANTIPSYCHOTICS, CLOZAPINE AND RISPERIDONE
    SCHREIBER, R
    BROCCO, M
    MILLAN, MJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 264 (01) : 99 - 102
  • [44] Activation of phosphatidylcholine-selective phospholipase C by I-1-imidazoline receptors in PC12 cells and rostral ventrolateral medulla
    Separovic, D
    Kester, M
    Haxhiu, MA
    Ernsberger, P
    [J]. BRAIN RESEARCH, 1997, 749 (02) : 335 - 339
  • [45] Separovic D, 1996, MOL PHARMACOL, V49, P668
  • [46] Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats:: down-regulation of the 5-HT2A, but not 5-HT2C, receptor
    Smith, RL
    Barrett, RJ
    Sanders-Bush, E
    [J]. PSYCHOPHARMACOLOGY, 1999, 144 (03) : 248 - 254
  • [47] TEITLER M, 1990, MOL PHARMACOL, V38, P594
  • [48] TITELER M, 1988, PSYCHOPHARMACOLOGY, V94, P213
  • [49] Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line - Involvement of arachidonic acid metabolism
    Tournois, C
    Mutel, V
    Manivet, P
    Launay, JM
    Kellermann, O
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (28) : 17498 - 17503
  • [50] WINTER JC, 1975, ARCH INT PHARMACOD T, V214, P250